NCR1 and lymphoma: Consistent with this process, Myc-driven lymphomas from NKG2D–deficient mice or MCA-induced tumors from NKp46-deficient mice display stronger expression of NKG2D and NKp46 ligands, respectively, than tumors isolated from WT mice (15, 17).